publication date: Sep. 20, 2019

Clinical Roundup

Higher patient volumes associated with longer survival in multiple myeloma

Providers with more experience treating people with multiple myeloma have better outcomes than those with more limited experience, according to a study in the September issue of the Journal of the National Comprehensive Cancer Network.

In general, providers who saw the most cases were more likely to be located at academic, NCI-designated cancer centers. However, the researchers found that the very highest-volume providers at community facilities did achieve equally low mortality rates as clinicians at NCI- designated cancer centers.

The study was based on data from 1,029 patients in the University of North Carolina Cancer Information and Population Health Resource who were diagnosed with multiple myeloma between 2006 and 2012. People who did not have continuous insurance enrollment for 6 months before and 12 months after diagnosis were excluded, along with those who did not receive chemotherapy within 12 months of diagnosis. Patients ranged in age from 25 to 98 years, with a mean of 68.

“Our results show that provider experience, and potentially access to resources at a comprehensive cancer center, may improve survival in patients with multiple myeloma. The reasons might have to do with familiarity with the benefits and best use of newer drugs and regimens, access to resources to help with management of toxicities or complications, or other factors. Or, it might be that patients who are seen by higher volume providers are more likely to have other unmeasured or confounding factors associated with better survival. More research is needed to help sort this out,” senior researcher William A. Wood, of UNC Lineberger Comprehensive Cancer Center, said in a statement.

The researchers found that … Continue reading Higher patient volumes associated with longer survival in multiple myeloma

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.